Cargando…

RUNX1, a new regulator of EMT in breast cancer

Detalles Bibliográficos
Autores principales:	Khawaled, Saleh, Aqeilan, Rami I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	News
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392256/ https://www.ncbi.nlm.nih.gov/pubmed/28407696 http://dx.doi.org/10.18632/oncotarget.15623

Ejemplares similares

RUNX1 and breast cancer
por: Mercado-Matos, Jose, et al.
Publicado: (2017)

AntimiR-155 Cyclic Peptide–PNA Conjugate: Synthesis, Cellular Uptake, and Biological Activity
por: Soudah, Terese, et al.
Publicado: (2019)

Tumor Suppressor WWOX inhibits osteosarcoma metastasis by modulating RUNX2 function
por: Del Mare, Sara, et al.
Publicado: (2015)

RUNX1 and RUNX3 protect against YAP-mediated EMT, stem-ness and shorter survival outcomes in breast cancer
por: Kulkarni, Madhura, et al.
Publicado: (2018)

RUNX oncoproteins and miRNA networks
por: Neil, James C., et al.
Publicado: (2017)

Fumarate drives EMT in renal cancer
por: Sciacovelli, Marco, et al.
Publicado: (2017)

miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells
por: Salah, Zaidoun, et al.
Publicado: (2015)

Stem cells: a window of opportunity in low-dimensional EMT space
por: Nie, Qing
Publicado: (2018)

Combined shRNA over CRISPR/cas9 as a methodology to detect off-target effects and a potential compensatory mechanism
por: Peretz, Liat, et al.
Publicado: (2018)

A new dimension in drug discovery: reversing epithelial–mesenchymal transition (EMT)
por: Yun-Ju Huang, Ruby, et al.
Publicado: (2016)

FHIT Suppresses Epithelial-Mesenchymal Transition (EMT) and Metastasis in Lung Cancer through Modulation of MicroRNAs
por: Suh, Sung-Suk, et al.
Publicado: (2014)

CDK8: a new breast cancer target
por: Crown, John
Publicado: (2017)

FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer
por: Casalino, Laura, et al.
Publicado: (2023)

Pleiotropic tumor suppressor functions of WWOX antagonize metastasis
por: Khawaled, Saleh, et al.
Publicado: (2020)

RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer
por: Li, Qingyuan, et al.
Publicado: (2019)

DVL regulation of tissue-specific aromatase transcripts in breast cancer
por: O’Hagan, Heather M.
Publicado: (2018)

On the connections between cancer stem cells and EMT
por: Cioce, Mario, et al.
Publicado: (2012)

Loss of Stemness, EMT, and Supernumerary Tooth Formation in Cebpb(−/−)Runx2(+/−) Murine Incisors
por: Saito, Kazuyuki, et al.
Publicado: (2018)

The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway
por: Salah, Zaidoun, et al.
Publicado: (2014)

Engineering organoids: a promising platform to understand biology and treat diseases
por: Aqeilan, Rami I.
Publicado: (2020)

RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes
por: Recouvreux, María Sol, et al.
Publicado: (2015)

MicroRNAs: New Players in Multiple Myeloma
por: Pichiorri, Flavia, et al.
Publicado: (2011)

MiRNAs prognostic for basal and BRCA1 breast cancer
por: Pal, Bhupinder, et al.
Publicado: (2018)

RUNX regulated immune-associated genes predicts prognosis in breast cancer
por: Fu, Jingyue, et al.
Publicado: (2022)

Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death
por: Sugimoto, H, et al.
Publicado: (2015)

RUNX1-Regulated Signaling Pathways in Ovarian Cancer
por: Chen, Yuanzhi, et al.
Publicado: (2023)

A role for EMT in CD73 regulation in breast cancer
por: Hasmim, Meriem, et al.
Publicado: (2022)

Lipid is new Star in nuclear regulation
por: Robinson, Richard
Publicado: (2008)

RUNX3 regulates hepatocellular carcinoma cell metastasis via targeting miR-186/E-cadherin/EMT pathway
por: Gou, Yuli, et al.
Publicado: (2017)

Prolyl isomerase Pin1 down-regulates tumor suppressor RUNX3 in breast cancer
por: Tsang, Ying-Hung Nicole, et al.
Publicado: (2012)

SNORA71C promotes development and metastasis of breast cancer by regulating RUNX1 and ferroptosis
por: Xie, Bumin, et al.
Publicado: (2023)

Somatic loss of WWOX is associated with TP53 perturbation in basal-like breast cancer
por: Abdeen, Suhaib K., et al.
Publicado: (2018)

New light on Smac mimetics and breast cancer
por: Cornmark, L, et al.
Publicado: (2016)

Impact of Nischarin on EMT regulators in breast cancer cell lines
por: Cai, Yuan-Jie, et al.
Publicado: (2020)

Regulation of brain insulin signaling: A new function for tau
por: Gratuze, Maud, et al.
Publicado: (2017)

Holothurin A Inhibits RUNX1-Enhanced EMT in Metastasis Prostate Cancer via the Akt/JNK and P38 MAPK Signaling Pathway
por: Janta, Sirorat, et al.
Publicado: (2023)

Runx1: a new driver in neurofibromagenesis
por: Wu, Jianqiang, et al.
Publicado: (2015)

Allelic imbalance in human breast cancer
por: French, Juliet D., et al.
Publicado: (2017)

A target of potential RELAvance in inflammatory breast cancer
por: Eckhardt, Bedrich L., et al.
Publicado: (2017)

CMTM6 and CMTM7: New leads for PD‐L1 regulation in breast cancer cells undergoing EMT
por: Xiao, Malina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ou7eli28so2diqt0busd1so44q